---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-045513"
form_type: "8-K"
ticker: "CNTX"
cik: "0001842952"
company_name: "Context Therapeutics Inc."
filed_at: "2025-10-20T23:59:59+00:00"
generated_at: "2026-05-17T03:17:03.141663+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Context Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq letter on Oct 17, 2025 confirming compliance regained after 10 consecutive business days with closing bid price at or above $1.00.
- Company had been noncompliant since Feb 27, 2025; granted extension to Feb 23, 2026.
- Nasdaq considers the matter closed; delisting risk removed.
- Stock ticker CNTX trades on Nasdaq under Minimum Bid Price Rule 5550(a)(2).

## SEC filing metadata
- accession: 0001628280-25-045513
- form_type: 8-K
- ticker: CNTX
- cik: 0001842952
- company_name: Context Therapeutics Inc.
- filed_at: 2025-10-20T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1842952/000162828025045513/0001628280-25-045513-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1842952/000162828025045513/cntx-20251017.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-045513
- JSON: https://secwatch.observer/filing/0001628280-25-045513.json
- Plain text: https://secwatch.observer/filing/0001628280-25-045513.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.